immunology-research-tissue-science-2018-tracks

4 / 25

Journal of Transmitted Diseases and Immunity
ISSN: 2573-0320 Page 30
Volume 4
May 10-11, 2018
Frankfurt, Germany
Immunology Research 2018
Tissue Science 2018
JOINT EVENT
2 2 n d E d i t i o n o f I n t e r n a t i o n a l C o n f e r e n c e o n
Immunology and
Evolution of Infectious Diseases
&
1 2 t h E d i t i o n o f I n t e r n a t i o n a l C o n f e r e n c e o n
Tissue Engineering and
Regenerative Medicine
T here is an increasing prevalence of antibiotic resistant
bacteria. This makes traditional antibiotics less effective.
More than 25000 people in Europe die each year from
infections of resistant bacteria. This emphasizes the need to
find alternatives to antibiotics. The drug should fight infections,
it should not give resistant bacteria or viruses, it should be
easy to scale up and it should be cheap. Such a drug exists.
Avian antibodies from immunized hens act as strong weapons
against a series of common infections. Hence these can be
used either as a complement or an alternative to antibiotics. It
is high time for health authorities, pharmaceutical companies,
physicians, and researchers etc., to be involved in the fight
against infectious diseases by joining this strong pull for avian
antibodies-IgY. Clinical studies are carried out including use
of IgY will diminish the development of antibiotic resistant
microbes.
Biography
Hans Kollberg is Professor emeritus, Pediatrics, Children´s University Hos-
pital, Uppsala. He has a Specialization in Pediatrics from Swedish Medical
Board in 1966. He holds a Medical Doctors Degree (MD) in Pediatrics from
Uppsala University, Sweden 1961. He started his career as Staff Physician,
Good Samaritan Hospital, Phoenix, Arizona during 1959-1966. He extend-
ed his service as a Director of the CF Center, University Hospital, Uppsala
in 1968-1982 and Umea in 1985-1999. He was Professor at the University
of Kuwait during 1982-1985. He has been a recipient of many awards and
grants. He is the Founder of the Swedish Cystic Fibrosis Association. His
research experience includes various programs, contributions and partici-
pation in different countries for diverse fields of study. His research interests
as a Research Scholar reflect in his wide range of publications in various
national and international journals.
Antibodies instead of antibiotics to kill bacteria - experience
with anti-pseudo IgY with cystic fibrosis patients
Hans Kollberg
Uppsala University, Sweden
Hans Kollberg, J Transm Dis Immun 2018, Volume 2
DOI: 10.21767/2573-0320-C2-005